Found: 11
Select item for more details and to access through your institution.
Continuous glucose monitoring in 2010.
- Published in:
- International Journal of Clinical Practice (Supplement), 2011, v. 65, p. 10, doi. 10.1111/j.1742-1241.2010.02573.x
- By:
- Publication type:
- Article
Continuous glucose monitoring.
- Published in:
- International Journal of Clinical Practice (Supplement), 2010, v. 64, p. 11, doi. 10.1111/j.1742-1241.2009.02272.x
- By:
- Publication type:
- Article
Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2010, v. 12, n. 7, p. 604, doi. 10.1111/j.1463-1326.2010.01196.x
- By:
- Publication type:
- Article
Mealtime fast‐acting insulin aspart versus insulin aspart for controlling postprandial hyperglycaemia in people with insulin‐resistant Type 2 diabetes.
- Published in:
- Diabetic Medicine, 2019, v. 36, n. 6, p. 771, doi. 10.1111/dme.13866
- By:
- Publication type:
- Article
Safety and efficacy of insulin degludec/liraglutide ( IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin-naïve people with Type 2 diabetes: the DUAL IV trial.
- Published in:
- Diabetic Medicine, 2017, v. 34, n. 2, p. 189, doi. 10.1111/dme.13256
- By:
- Publication type:
- Article
Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN<sup>®</sup> Basal-Bolus Type 1): 2-year results of a randomized clinical trial
- Published in:
- Diabetic Medicine, 2013, v. 30, n. 11, p. 1293, doi. 10.1111/dme.12243
- By:
- Publication type:
- Article
Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN<sup>®</sup> Basal-Bolus Type 1): 2-year results of a...
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
One-year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26-week extension to a 26-week main trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 10, p. 965, doi. 10.1111/dom.12498
- By:
- Publication type:
- Article
Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide ( HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without metformin
- Published in:
- Diabetes, Obesity & Metabolism, 2014, v. 16, n. 12, p. 1257, doi. 10.1111/dom.12382
- By:
- Publication type:
- Article
Efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes.
- Published in:
- 1996
- By:
- Publication type:
- journal article